Cargando…
Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436709/ https://www.ncbi.nlm.nih.gov/pubmed/22958465 http://dx.doi.org/10.1186/2049-6958-7-15 |
_version_ | 1782242676989493248 |
---|---|
author | Dal Negro, Roberto W Tognella, Silvia Bonadiman, Luca Turco, Paola |
author_facet | Dal Negro, Roberto W Tognella, Silvia Bonadiman, Luca Turco, Paola |
author_sort | Dal Negro, Roberto W |
collection | PubMed |
description | BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort of 132 severe COPD patients (94 males; 71.4 years ± 8.8 sd), newly admitted to the tele-LTOT program, was investigated. Subjects were divided according to their original blood Hb: group A: <13 g/dL; group B: ≥13 < 15 g/dL; group C: ≥ 5 < 16 g/dL; group D: ≥16 g/dL. Blood Hb (g/dL), PaO(2) and PaCO(2) (mmHg), SaO(2) (%), and BMI were measured at LTOT admission (t(0)), and at least quarterly over three years (t(1)-t(3)). Wilcoxon test was used to compare t(0) vs. t(1) values; linear regression to assess a possible Hb-BMI relationship; ANOVA to compare changes in Hb time-courses over the 3 years. RESULTS: LTOT induced a systematic increase of PaO(2), and changes were significant since the first year (from 52.1 mmHg ± 6.6sd to 65.1 mmHg ± 8.7 sd, p < 0.001). Changes in SaO(2) were quite similar. Comparable and equally significant trends were seen in all subgroups (p < 0.001). PaCO(2) dropped within the first year of LTOT (from 49.4 mmHg ± 9.1sd to 45.9 mmHg ±7.5 sd, p < 0.001): the t(0)-t(1) comparison proved significant (p < 0.01) only in subgroups with the highest basal Hb, who showed a further PaCO(2) decline over the remaining two years (p < 0.001). Hb tended to normalization during LTOT only in subgroups with basal Hb > 15 g/dl (ANOVA p < 0.001); anemic subjects (Hb < 13 g/dl) ameliorated not significantly in the same period (ANOVA = 0.5). Survival was independent of the original blood Hb. Anemia and polyglobulia are differently prevalent in COPD, the latter being the most represented in our cohort. LTOT affected both conditions, but to a different extent and according to different time-courses. The most striking Hb improvement was in polyglobulic patients in whom also PaO(2), PaCO(2) and SaO(2) dramatically improved. In anemic subjects effects were smaller and slower, oxygenation being equally ameliorated by LTOT. CONCLUSIONS: LTOT effects on Hb and PaCO(2) are regulated by an Hb-dependent gradient which seems independent of the original impairment of blood gases and of effects on oxygenation. |
format | Online Article Text |
id | pubmed-3436709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34367092012-09-08 Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment Dal Negro, Roberto W Tognella, Silvia Bonadiman, Luca Turco, Paola Multidiscip Respir Med Original Article BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort of 132 severe COPD patients (94 males; 71.4 years ± 8.8 sd), newly admitted to the tele-LTOT program, was investigated. Subjects were divided according to their original blood Hb: group A: <13 g/dL; group B: ≥13 < 15 g/dL; group C: ≥ 5 < 16 g/dL; group D: ≥16 g/dL. Blood Hb (g/dL), PaO(2) and PaCO(2) (mmHg), SaO(2) (%), and BMI were measured at LTOT admission (t(0)), and at least quarterly over three years (t(1)-t(3)). Wilcoxon test was used to compare t(0) vs. t(1) values; linear regression to assess a possible Hb-BMI relationship; ANOVA to compare changes in Hb time-courses over the 3 years. RESULTS: LTOT induced a systematic increase of PaO(2), and changes were significant since the first year (from 52.1 mmHg ± 6.6sd to 65.1 mmHg ± 8.7 sd, p < 0.001). Changes in SaO(2) were quite similar. Comparable and equally significant trends were seen in all subgroups (p < 0.001). PaCO(2) dropped within the first year of LTOT (from 49.4 mmHg ± 9.1sd to 45.9 mmHg ±7.5 sd, p < 0.001): the t(0)-t(1) comparison proved significant (p < 0.01) only in subgroups with the highest basal Hb, who showed a further PaCO(2) decline over the remaining two years (p < 0.001). Hb tended to normalization during LTOT only in subgroups with basal Hb > 15 g/dl (ANOVA p < 0.001); anemic subjects (Hb < 13 g/dl) ameliorated not significantly in the same period (ANOVA = 0.5). Survival was independent of the original blood Hb. Anemia and polyglobulia are differently prevalent in COPD, the latter being the most represented in our cohort. LTOT affected both conditions, but to a different extent and according to different time-courses. The most striking Hb improvement was in polyglobulic patients in whom also PaO(2), PaCO(2) and SaO(2) dramatically improved. In anemic subjects effects were smaller and slower, oxygenation being equally ameliorated by LTOT. CONCLUSIONS: LTOT effects on Hb and PaCO(2) are regulated by an Hb-dependent gradient which seems independent of the original impairment of blood gases and of effects on oxygenation. BioMed Central 2012-07-17 /pmc/articles/PMC3436709/ /pubmed/22958465 http://dx.doi.org/10.1186/2049-6958-7-15 Text en Copyright ©2012 Dal Negro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Dal Negro, Roberto W Tognella, Silvia Bonadiman, Luca Turco, Paola Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title | Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title_full | Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title_fullStr | Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title_full_unstemmed | Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title_short | Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment |
title_sort | changes in blood hemoglobin and blood gases pao(2) and paco(2) in severe copd overa three-year telemonitored program of long-term oxygen treatment |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436709/ https://www.ncbi.nlm.nih.gov/pubmed/22958465 http://dx.doi.org/10.1186/2049-6958-7-15 |
work_keys_str_mv | AT dalnegrorobertow changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment AT tognellasilvia changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment AT bonadimanluca changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment AT turcopaola changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment |